Related Experiment Video
Updated: Jul 6, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Proteomics for the investigation of acute kidney injury
1Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA.
Abstract:
Acute kidney injury (AKI), previously referred to as acute renal failure (ARF), represents an important problem in clinical medicine. Despite significant improvements in therapeutics, the mortality and morbidity associated with AKI remain high. The reasons for this include (a) an incomplete understanding of the underlying pathophysiologic mechanisms, and (b) the lack of early markers for AKI, and hence an unacceptable delay in initiating therapy. Fortunately, the application of innovative technologies such as functional genomics and proteomics to human and animal models of AKI has uncovered several novel genes and proteins that are emerging as biomarkers and novel therapeutic targets. Recent advances in proteomics that hold promise in ischemic AKI, the most common and serious subtype of ARF, are chronicled in this article. These include the identification of biomarkers in the plasma (NGAL and cystatin C) and urine (NGAL, KIM-1, IL-18, cystatin C, alpha 1-microglobulin, fetuin-A, Gro-alpha, and meprin) for the investigation of AKI. It is likely that the AKI panels will be useful for timing the initial insult and assessing the duration of AKI. Based on the differential expression of the biomarkers, it is also likely that the AKI panels will distinguish between the various etiologies of AKI, and predict clinical outcomes.
Insights
New biomarkers for acute kidney injury (AKI) are emerging from proteomics research. These novel markers show promise for early detection, prognosis, and understanding AKI causes.
Area of Science:
- Biochemistry
- Nephrology
- Molecular Biology
Background:
- Acute kidney injury (AKI), also known as acute renal failure (ARF), is a significant clinical problem with high mortality and morbidity.
- Current challenges in managing AKI include a limited understanding of its pathophysiology and a lack of early diagnostic markers, leading to delayed treatment.
- Innovative technologies like functional genomics and proteomics are uncovering new therapeutic targets and biomarkers for AKI.
Purpose of the Study:
- To review recent advances in proteomics for identifying biomarkers in ischemic AKI, a common and severe subtype of ARF.
- To highlight novel protein biomarkers discovered in plasma and urine for AKI investigation.
- To discuss the potential of these biomarkers in assessing AKI timing, duration, etiology, and clinical outcomes.
Main Methods:
- Review of recent scientific literature focusing on proteomics and biomarker discovery in AKI.
- Analysis of studies identifying novel genes and proteins in human and animal models of AKI.
- Compilation of identified plasma and urine biomarkers, including NGAL, cystatin C, KIM-1, IL-18, alpha 1-microglobulin, fetuin-A, Gro-alpha, and meprin.
Main Results:
- Identification of several promising protein biomarkers in plasma (e.g., NGAL, cystatin C) and urine (e.g., NGAL, KIM-1, IL-18, cystatin C, alpha 1-microglobulin, fetuin-A, Gro-alpha, meprin) for AKI.
- Emerging evidence suggests these biomarkers can aid in determining the timing and duration of AKI.
- Differential expression patterns of biomarkers may help distinguish between various causes of AKI and predict patient outcomes.
Conclusions:
- Proteomics has uncovered novel biomarkers with significant potential for improving AKI diagnosis and management.
- These biomarkers may enable earlier detection, better characterization of AKI, and prediction of clinical outcomes.
- Further research and clinical validation are essential to fully integrate these proteomic discoveries into routine AKI care.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
